These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 2887315)
1. Cardiovascular characterization of DA-1 and DA-2 dopamine receptor agonists in anesthetized rats. Cavero I; Thiry C; Pratz J; Lawson K Clin Exp Hypertens A; 1987; 9(5-6):931-52. PubMed ID: 2887315 [TBL] [Abstract][Full Text] [Related]
2. Cardiovascular characterization of the DA2 dopamine receptor agonist quinpirole in rats. Lefevre-Borg F; Lorrain J; Lechaire J; Thiry C; Lhoste F; Hicks PE; Cavero I Fundam Clin Pharmacol; 1987; 1(3):179-200. PubMed ID: 2892767 [TBL] [Abstract][Full Text] [Related]
3. Characterization of the hypotensive action of dopamine receptor agonists fenoldopam and quinpirole in anaesthetized rats. Sengupta S; Lokhandwala MF J Auton Pharmacol; 1985 Dec; 5(4):289-94. PubMed ID: 2869041 [TBL] [Abstract][Full Text] [Related]
4. Influence of the dopamine receptor agonists fenoldopam and quinpirole in the rat superior mesenteric vascular bed. Dupont AG; Lefebvre RA; Vanderniepen P Br J Pharmacol; 1987 Jul; 91(3):493-501. PubMed ID: 2886174 [TBL] [Abstract][Full Text] [Related]
5. Hypotensive and bradycardic effects elicited by spinal dopamine receptor stimulation: effects of D1 and D2 receptor agonists and antagonists. Pellissier G; Demenge P J Cardiovasc Pharmacol; 1991 Oct; 18(4):548-55. PubMed ID: 1724532 [TBL] [Abstract][Full Text] [Related]
6. SK&F 87516, a close analog of fenoldopam, is a partial agonist at dopamine-1 and alpha-2 receptors and produces stimulation of 5-hydroxytryptamine-2 receptors in the cardiovascular system of the rat. Le Monnier de Gouville AC; Lawson K; Thiry C; Cavero I J Pharmacol Exp Ther; 1991 Mar; 256(3):1049-56. PubMed ID: 1672375 [TBL] [Abstract][Full Text] [Related]
7. Hypotensive and regional haemodynamic effects of fenoldopam and quinpirole in the anaesthetized rat. Van der Niepen P; Dupont AG; Finne E; Six RO J Hypertens Suppl; 1988 Dec; 6(4):S687-9. PubMed ID: 2907350 [TBL] [Abstract][Full Text] [Related]
8. Studies on the mechanisms of the development of tolerance to the hypotensive effects of fenoldopam in rats. Lefèvre-Borg F; Lorrain J; Lechaire J; Thiry C; Hicks PE; Cavero I J Cardiovasc Pharmacol; 1988 Apr; 11(4):444-55. PubMed ID: 2453748 [TBL] [Abstract][Full Text] [Related]
10. Involvement of cyclic-AMP in the hypotensive response to fenoldopam but not to quinpirole in the anaesthetized rat. Hegde SS; Lokhandwala MF J Auton Pharmacol; 1988 Mar; 8(1):63-8. PubMed ID: 2455721 [TBL] [Abstract][Full Text] [Related]
11. Increase in plasma renin activity evoked by fenoldopam in dogs is directly mediated by dopamine1 receptor stimulation. Montier F; Katchadourian P; Pratz J; Cavero I J Cardiovasc Pharmacol; 1989 May; 13(5):739-47. PubMed ID: 2472522 [TBL] [Abstract][Full Text] [Related]
12. Pharmacological, hemodynamic and autonomic nervous system mechanisms responsible for the blood pressure and heart rate lowering effects of pergolide in rats. Cavero I; Lefevre-Borg F; Lhoste F; Sabatier C; Richer C; Giudicelli JF J Pharmacol Exp Ther; 1984 Mar; 228(3):779-91. PubMed ID: 6707926 [TBL] [Abstract][Full Text] [Related]
13. Rat juxtaglomerular cells are endowed with DA-1 dopamine receptors mediating renin release. Kurtz A; Della Bruna R; Pratz J; Cavero I J Cardiovasc Pharmacol; 1988 Dec; 12(6):658-63. PubMed ID: 2467083 [TBL] [Abstract][Full Text] [Related]
14. Pharmacological, hemodynamic and biochemical mechanisms involved in the blood pressure lowering effects of pergolide, in normotensive and hypertensive dogs. Cavero I; Lorrain J; Di Paola ED; Lhoste F; Payen B; Dennis T; Scatton B J Pharmacol Exp Ther; 1985 Dec; 235(3):798-809. PubMed ID: 2934543 [TBL] [Abstract][Full Text] [Related]
15. Identification of dopamine receptor subtypes in the hypotensive action of SK&F 85174 in anesthetized rats. Sowinski BA; Lokhandwala MF J Auton Pharmacol; 1987 Jun; 7(2):105-9. PubMed ID: 2888767 [TBL] [Abstract][Full Text] [Related]
16. Activation of DA1 receptors by dopamine or fenoldopam increases cyclic AMP levels in the renal artery but not in the superior cervical ganglion of the rat. Alkadhi KA; Sabouni MH; Ansari AF; Lokhandwala MF J Pharmacol Exp Ther; 1986 Aug; 238(2):547-53. PubMed ID: 2874213 [TBL] [Abstract][Full Text] [Related]
17. Suppression of sympathetic ganglionic neurotransmission by the selective dopamine-1 receptor agonist fenoldopam (SK&F 82526) in the anesthetized dog. Shebuski RJ; Fujita T; Smith JM; Kopaciewicz LJ; Blumberg AL; Hieble JP J Pharmacol Exp Ther; 1985 Dec; 235(3):735-40. PubMed ID: 2867207 [TBL] [Abstract][Full Text] [Related]
18. Pharmacological characterization of dopamine receptors in the stellate ganglia with selective DA1 and DA2 receptor agonists and antagonists. Sabouni MH; Alkadhi KA; Lokhandwala MF J Pharmacol Exp Ther; 1986 Jan; 236(1):65-70. PubMed ID: 2867216 [TBL] [Abstract][Full Text] [Related]
19. Effects of the dopamine receptor agonists, fenoldopam and quinpirole, in the rat stomach. Lefebvre RA; Guenaneche F; De Beurme FA Eur J Pharmacol; 1990 Aug; 185(1):69-79. PubMed ID: 1977599 [TBL] [Abstract][Full Text] [Related]
20. Selective antagonism of the hypotensive effects of dopamine agonists in spontaneously hypertensive rats. McCoy CE; Douglas FL; Goldberg LI Hypertension; 1986 Apr; 8(4):298-302. PubMed ID: 2870024 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]